Solitary and Complicated Neurofibroma of Small Bowel: A Case Report

Overview

Journal Int J Surg Case Rep

Specialty General Surgery

Date 2020 Dec 19

PMID 33340979

Authors

Hassane Ait Ali

Brahim Zeriouh

Usman Egyir Ebo

Badr Serji

Tijani Elharroudi

Affiliations

Soon will be listed here.

Abstract

Introduction: Neurofibromatosis is a genetic disorder characterized by tumors and pigmentary changes on the skin, such as spots that color leans to 'White Coffee'. Neurofibromas of the gastrointestinal tract are commonly associated with neurofibromatosis type I (NF1). Although, digestive involvement can be the single manifestation of the disease and may consequently; represent the only diagnostic element.

Presentation Of Case: We report here; a case of a patient admitted to the emergency department with a bowel obstruction, for which radiological investigations revealed the presence of intussusception due to an intestinal tumor. The patient underwent a bowel resection with anastomosis, and then, after being examined histologically, the result has identified an intestinal neurofibroma without evidence of malignancy. Then and on the fourth day following the surgery, the patient was discharged with good clinical improvement.

Discussion: The intestinal neurofibroma may be the first and the only manifestation of neurofibromatosis type I. Also, it's uncommon to present a neurofibroma isolated from the small bowel with an intussusception, which makes the pre-surgical diagnosis very difficult. And until now, only a few case reports of these conditions have been reported.

Conclusion: We report this uncommon clinical case of an isolated neurofibroma from the small bowel to raise awareness among the medical team about this exceptional pathology. Nevertheless, its risk of developing serious complications and malignant transformation led us to opt for earlier surgical treatment. Furthermore, it requires a close clinical follow-up to eliminate the neurofibromatosis type I or the multiple endocrine neoplasia type II.

References

Reynolds R, Browning G, Nawroz I, Campbell I . Von Recklinghausen's neurofibromatosis: neurofibromatosis type 1. Lancet. 2003; 361(9368):1552-4. DOI: 10.1016/s0140-6736(03)13166-2. View

Cavallaro G, Crocetti D, Pedulla G, Giustini S, Letizia C, De Toma G . Retrocaval mass in patient with von Recklinghausen disease: case report. G Chir. 2012; 33(1-2):26-30. View

Hwang I, Hahn S, Kim H, Kim S, Kim H, Shin K . Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1. Cancer Res Treat. 2017; 49(3):717-726. PMC: 5512378. DOI: 10.4143/crt.2016.271. View

Gerber P, Antal A, Neumann N, Homey B, Matuschek C, Peiper M . Neurofibromatosis. Eur J Med Res. 2009; 14(3):102-5. PMC: 3352057. DOI: 10.1186/2047-783x-14-3-102. View

Brems H, Beert E, de Ravel T, Legius E . Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol. 2009; 10(5):508-15. DOI: 10.1016/S1470-2045(09)70033-6. View

Ruggieri M, Huson S . The neurofibromatoses. An overview. Ital J Neurol Sci. 2000; 20(2):89-108. DOI: 10.1007/s100720050017. View

Hechtman J, Harpaz N . Neurogenic polyps of the gastrointestinal tract: a clinicopathologic review with emphasis on differential diagnosis and syndromic associations. Arch Pathol Lab Med. 2014; 139(1):133-9. DOI: 10.5858/arpa.2013-0431-RS. View

Sun W, Pandey A, Lee M, Wasilenko S, Karmali S . Isolated colonic neurofibroma in the setting of Lynch syndrome: A case report and review of literature. World J Gastrointest Surg. 2020; 12(1):28-33. PMC: 6943092. DOI: 10.4240/wjgs.v12.i1.28. View

Cavallaro G, Basile U, Polistena A, Giustini S, Arena R, Scorsi A . Surgical management of abdominal manifestations of type 1 neurofibromatosis: experience of a single center. Am Surg. 2010; 76(4):389-96. View

10.

Watanuki F, Ohwada S, Hosomura Y, Okamura S, Kawashima Y, Tanahashi Y . Small ileal neurofibroma causing intussusception in a non-neurofibromatosis patient. J Gastroenterol. 1995; 30(1):113-6. DOI: 10.1007/BF01211385. View

11.

Rastogi R . Intra-abdominal manifestations of von Recklinghausen's neurofibromatosis. Saudi J Gastroenterol. 2009; 14(2):80-2. PMC: 2702901. DOI: 10.4103/1319-3767.39623. View

12.

Lefere I, Dalle I, Thieren H, Decock S, Ramboer K . Diffuse intestinal ganglioneuromatosis of the ileum. JBR-BTR. 2012; 95(3):152-3. DOI: 10.5334/jbr-btr.596. View

13.

RIVER L, Silverstein J, TOPE J . Benign neoplasms of the small intestine; a critical comprehensive review with reports of 20 new cases. Surg Gynecol Obstet. 1956; 102(1):1-38. View

14.

Levy A, Patel N, Dow N, Abbott R, Miettinen M, Sobin L . From the archives of the AFIP: abdominal neoplasms in patients with neurofibromatosis type 1: radiologic-pathologic correlation. Radiographics. 2005; 25(2):455-80. DOI: 10.1148/rg.252045176. View

15.

Agha R, Borrelli M, Farwana R, Koshy K, Fowler A, Orgill D . The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines. Int J Surg. 2018; 60:132-136. DOI: 10.1016/j.ijsu.2018.10.028. View

16.

Razek A . MR imaging of neoplastic and non-neoplastic lesions of the brain and spine in neurofibromatosis type I. Neurol Sci. 2018; 39(5):821-827. DOI: 10.1007/s10072-018-3284-7. View

17.

Jett K, Friedman J . Clinical and genetic aspects of neurofibromatosis 1. Genet Med. 2009; 12(1):1-11. DOI: 10.1097/GIM.0b013e3181bf15e3. View

18.

Al-Harake A, Chour M, Al Beteddini O . Solitary intestinal neurofibroma with no associated systemic syndromes causing intussusception: Case report and literature review. Int J Surg Case Rep. 2013; 4(7):629-32. PMC: 3679427. DOI: 10.1016/j.ijscr.2013.03.036. View

19.

Agaimy A, Vassos N, Croner R . Gastrointestinal manifestations of neurofibromatosis type 1 (Recklinghausen's disease): clinicopathological spectrum with pathogenetic considerations. Int J Clin Exp Pathol. 2012; 5(9):852-62. PMC: 3484498. View

20.

Davis G, Berk R . Intestinal neurofibromas in von Recklinghausen's disease. Am J Gastroenterol. 1973; 60(4):410-4. View